Global Animal External Parasiticide Market Size By Type (Injection, Unguent), By Application (Livestock, Pets), By Region, And Segment Forecasts, 2023 to 2032

The Global Animal External Parasiticide Market was valued at USD 4.1 billion in 2023 and is projected to reach USD 6.7 billion by 2031, expanding at a CAGR of 6.2% from 2023 to 2031. The market is primarily driven by the increasing incidence of parasitic infestations among livestock and companion animals, heightened awareness about animal health, and the growing demand for animal-based products. External parasiticides play a vital role in preventing and controlling infestations caused by fleas, ticks, mites, and lice, thereby safeguarding animal well-being and productivity.

The rise in pet ownership, coupled with the commercialization of animal healthcare products, has further amplified demand. Increasing regulatory support and innovations in novel delivery methods such as spot-ons, sprays, and pour-ons are expected to contribute significantly to the market's sustained growth.

Drivers:

1. Growing Pet Ownership and Companion Animal Spending:

Rising global pet adoption and increasing expenditure on pet care are propelling the demand for external parasiticides. Pet owners are more inclined to invest in preventive healthcare, including flea and tick protection.

2. Rising Incidence of Vector-Borne Diseases:

The prevalence of vector-borne diseases such as Lyme disease and anaplasmosis in animals is on the rise. This is fueling the need for efficient parasiticides to manage external parasites that act as disease vectors.

3. Focus on Livestock Health for Food Safety:

External parasites impact livestock performance and meat/milk productivity. The growing importance of animal welfare and productivity in livestock farming is pushing the adoption of parasiticides in the agricultural sector.

Restraints:

1. Stringent Regulatory Approval Process:

The market is restrained by the lengthy and costly regulatory approval procedures for veterinary pharmaceuticals, including parasiticides, especially in regions with tight oversight like Europe and North America.

2. Development of Parasite Resistance:

Continuous and improper use of external parasiticides can lead to resistance in parasite populations, diminishing the effectiveness of existing treatments and limiting market growth.

Opportunity:

1. Innovation in Product Formulations:

There is growing interest in long-acting formulations, plant-based parasiticides, and combined parasite control solutions. Such innovations present lucrative growth avenues for market participants.

2. Penetration into Emerging Markets:

Developing regions in Asia-Pacific, Latin America, and Africa are witnessing increased livestock production and pet care adoption. These areas offer untapped potential for parasiticide manufacturers.

Market by System Type Insights:

Based on system type, the Spot-On Products segment accounted for the largest revenue share in 2023. Spot-on formulations are user-friendly, offer prolonged protection, and are effective against a broad spectrum of external parasites. Innovations enhancing water-resistance and sustained release are expected to drive this segment further. The Sprays & Pour-Ons segment is also witnessing growth due to its cost-effectiveness and applicability in livestock.

Market by End-Use Insights:

By end-use, the Livestock segment dominated the global market in 2023. External parasites such as ticks and lice significantly affect cattle, sheep, and goats, prompting widespread use of parasiticides in commercial farming. The Companion Animal segment is expected to exhibit the highest CAGR during the forecast period, spurred by increasing pet adoption rates and the humanization of pets.

Market by Regional Insights:

Geographically, North America led the global market in 2023, driven by high pet ownership, awareness of preventive veterinary care, and the presence of leading pharmaceutical companies. However, the Asia-Pacific region is anticipated to grow at the fastest pace, supported by rising livestock farming, expanding veterinary infrastructure, and increasing investment in animal healthcare in countries such as China, India, and Vietnam.

Competitive Scenario:

Prominent players in the Global Animal External Parasiticide Market include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim, Merck Animal Health, Virbac SA, Bayer AG, Vetoquinol SA, Ceva Santé Animale, and Dechra Pharmaceuticals. Key strategies adopted by these companies include strategic acquisitions, product innovations, and regional expansions.

Key Market Developments:

In 2023, Zoetis launched a new line of long-acting topical parasiticides tailored for livestock in tropical regions.

Elanco introduced a chewable ectoparasiticide for dogs with enhanced palatability and fast action in 2024.

Virbac SA entered a strategic alliance with a regional distributor in Southeast Asia in 2025 to expand its parasiticide portfolio.

Scope of Work – Global Animal External Parasiticide Market

FAQs:

1) What is the current market size of the Global Animal External Parasiticide Market?

The market was valued at USD 4.1 billion in 2023.

2) What is the major growth driver of the Global Animal External Parasiticide Market?

The major growth driver is the rising incidence of vector-borne diseases among animals and the growing awareness of animal health and hygiene.

3) Which is the largest region during the forecast period in the Global Animal External Parasiticide Market?

North America dominated in 2023, but Asia-Pacific is projected to witness the fastest growth during the forecast period.

4) Which segment accounted for the largest market share in the Global Animal External Parasiticide Market?

The Spot-On Products segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Animal External Parasiticide Market?

Key players include Zoetis Inc., Elanco, Boehringer Ingelheim, Merck Animal Health, Virbac SA, Bayer AG, and Ceva Santé Animale.